Table 5. ORs comparison between Group 1 (cervical cancer) and Group 2 (HPV positive without cervical cancer).

Genotype	Group 1 (n = 285)	Group 2 (n = 225)	OR* (95% CI)	P	OR* (95% CI)	P
	No. (%)	No. (%)
GG	247 (86.7)	188 (83.6)	Reference		1.508(0.569–3.998)	0.409
GA	30 (10.5)	28 (12.4)	0.785(0.451–1.368)	0.393	1.184(0.398–3.523)	0.761
AA	8 (2.8)	9 (4.0)	0.663(0.250–1.758)	0.409	reference
GG+GA	277 (97.2)	216 (96.0)	Reference		1.468 (0.555–3.882)	0.439
AA	8 (2.8)	9 (4.0)	0.681(0.258–1.802)	0.439	reference
GA+AA	38 (13.3)	37 (16.4)	Reference		0.755 (0.460–1.239)	0.266
GG	247 (86.7)	188 (83.6)	1.324 (0.807–2.173)	0.266	reference

Note: ^*Data were calculated by multivariate regression analysis, adjusting for age, smoking status and HPV status.